BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 1990293)

  • 1. Intracellular leucine zipper interactions suggest c-Myc hetero-oligomerization.
    Dang CV; Barrett J; Villa-Garcia M; Resar LM; Kato GJ; Fearon ER
    Mol Cell Biol; 1991 Feb; 11(2):954-62. PubMed ID: 1990293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An amino-terminal c-myc domain required for neoplastic transformation activates transcription.
    Kato GJ; Barrett J; Villa-Garcia M; Dang CV
    Mol Cell Biol; 1990 Nov; 10(11):5914-20. PubMed ID: 2233723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-myc inhibits neoplastic transformation and transcriptional activation by c-myc.
    Resar LM; Dolde C; Barrett JF; Dang CV
    Mol Cell Biol; 1993 Feb; 13(2):1130-6. PubMed ID: 8423780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.
    Hunger SP; Li S; Fall MZ; Naumovski L; Cleary ML
    Blood; 1996 Jun; 87(11):4607-17. PubMed ID: 8639829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the conserved leucines in the leucine zipper dimerization motif of yeast GCN4.
    van Heeckeren WJ; Sellers JW; Struhl K
    Nucleic Acids Res; 1992 Jul; 20(14):3721-4. PubMed ID: 1641337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Max: functional domains and interaction with c-Myc.
    Kato GJ; Lee WM; Chen LL; Dang CV
    Genes Dev; 1992 Jan; 6(1):81-92. PubMed ID: 1730412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
    J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic activity of the c-Myc protein requires dimerization with Max.
    Amati B; Brooks MW; Levy N; Littlewood TD; Evan GI; Land H
    Cell; 1993 Jan; 72(2):233-45. PubMed ID: 8425220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. v-Myc, but not Max, possesses domains that function in both transcription activation and cellular transformation.
    Min S; Taparowsky EJ
    Oncogene; 1992 Aug; 7(8):1531-40. PubMed ID: 1630816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation and transactivation suppressor activity of the c-Jun leucine zipper fused to a bacterial repressor.
    Granger-Schnarr M; Benusiglio E; Schnarr M; Sassone-Corsi P
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4236-9. PubMed ID: 1584758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rice functional transcriptional activator, RISBZ1, responsible for endosperm-specific expression of storage protein genes through GCN4 motif.
    Onodera Y; Suzuki A; Wu CY; Washida H; Takaiwa F
    J Biol Chem; 2001 Apr; 276(17):14139-52. PubMed ID: 11133985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.
    Barrett J; Birrer MJ; Kato GJ; Dosaka-Akita H; Dang CV
    Mol Cell Biol; 1992 Jul; 12(7):3130-7. PubMed ID: 1620120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of a dominant-negative mutant of c-Jun.
    Brown PH; Chen TK; Birrer MJ
    Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation.
    Brough DE; Hofmann TJ; Ellwood KB; Townley RA; Cole MD
    Mol Cell Biol; 1995 Mar; 15(3):1536-44. PubMed ID: 7862146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly conserved residues in the bZIP domain of yeast GCN4 are not essential for DNA binding.
    Pu WT; Struhl K
    Mol Cell Biol; 1991 Oct; 11(10):4918-26. PubMed ID: 1922025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The retinoblastoma susceptibility gene product regulates Myc-mediated transcription.
    Adnane J; Robbins PD
    Oncogene; 1995 Jan; 10(2):381-7. PubMed ID: 7838535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
    Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
    Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation.
    Ghosh AK; Steele R; Ray RB
    Mol Cell Biol; 1999 Apr; 19(4):2880-6. PubMed ID: 10082554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The leucine zippers of the HLH-LZ proteins Max and c-Myc preferentially form heterodimers.
    Muhle-Goll C; Nilges M; Pastore A
    Biochemistry; 1995 Oct; 34(41):13554-64. PubMed ID: 7577944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.